Dishman Pharma on Saturday said that US Food & Drug Association (FDA) has completed an inspection at its Bavla plant on July 8. The regulatory body audited all the facilities and products of the company, says JR Vyas, CMD of the company. Two minor observations pertaining to a 2014 audit were reported by the US FDA, Vyas says. Export to US is expected to continue as earlier post the audit.Watch video for more..
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
